ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1970

Comparison of Optical Imaging with Musculoskeletal Ultrasound in Assessment of PIP Joints of Systemic Lupus Erythematosus Patients

Wei Tang1, Giovanna Rosas Chavez2, Leila Khalili2, Alberto Nordmann-Gomes3, Stephen Suh4, Alessandro Marone5, Moegammad Bardien5, Stephen Kim5, Laura Geraldino-Pardilla6, Andreas Hielscher5 and Anca Askanase2, 1Westchester Medical Center, Valhalla, NY, 2Columbia University Medical Center, New York, NY, 3Columbia University Irving Medical Center, New York, NY, 4Columbia University Irving Medical Center, New York City, NY, 5New York University Tandon School of Engineering, New York, NY, 6Columbia University, New York, NY

Meeting: ACR Convergence 2025

Keywords: Imaging, Joint Structure, Measurement Instrument, Systemic lupus erythematosus (SLE), Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1936–1971) Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Lupus arthritis has heterogeneous phenotypes and severity, complicating clinical management and trial endpoints. Advances in musculoskeletal ultrasound (MSK US) and optical imaging have been proposed as objective assessment tools. In a prior study of 20 systemic lupus erythematosus (SLE) patients, we demonstrated that frequency-domain optical imaging (FDOI) and a glove-like optical imaging system (GLOIS) can differentiate inflamed from normal joints by measuring transmitted and reflected lights to assess changes in tissue properties. Here we present extended data comparing FDOI with MSK US in evaluating lupus arthritis, and exploratory findings using GLOIS to monitor arthritis resolution.

Methods: We evaluated 31 SLE patients and 22 healthy controls via convenience sampling. For each subject, 8 proximal interphalangeal (PIP) joints (bilateral PIPs 2–5) were evaluated by FDOI and MSK US within two hours. MSK US used multiplanar grey-scale (GS) and power Doppler (PD) imaging, scored by OMERACT definitions to generate a composite PDGS score. FDOI employed a 670 nm, 8 mW laser modulated at 300 MHz, and scanned across each PIP to reconstruct three-dimensional (3D) maps of light absorption and scattering. Additionally, 2 SLE patients and 2 healthy controls underwent GLOIS evaluation (Fig 1), and 1 SLE patient was evaluated by GLOIS before and after therapy for an arthritis flare. GLOIS (Fig 1) used flexible bands with 8 optical modules (each with a photodiode and 3 LEDs at 530, 660, and 880 nm). LEDs were sequentially activated; photodiodes captured the transmitted signals. A sphygmomanometer was inflated to the subject’s diastolic blood pressure, inducing a complete venous occlusion and partial arterial occlusion, then released after 60 seconds accompanied by 60 more seconds of measurement. Subsequently, the measurements from all the source/detector pairs around the finger joint were used to tomographically reconstruct the distributions of total hemoglobin (HbT) concentrations in the joint.

Results: FDOI data (Fig 2) from 235 PIPs (SLE) and 136 PIPs (controls) produced an AUC of 0.87, with 89% sensitivity and 66% specificity (Fig 2A, 2B). Among 120 joints assessed by MSK US, PDGS scores were 0 (n=47), 1 (n=73), 2 (n=61), and 3 (n=54). Joints with moderate/severe arthritis (PDGS 2–3) had significantly higher scattering (8.8±1.4 vs. 8.3±0.6/cm, p< 0.01, Fig 2C) and absorption coefficients (0.25±0.18 vs. 0.18±0.1/cm, p< 0.01, Fig 2D) than those with minimal/no inflammation (PDGS 0–1).3D tomographically reconstructed GLOIS imaging showed higher HbT concentration at pressure release (Fig 3A) and 30 seconds post-release (Fig 3B) in SLE joints (42 μM at both timepoints) with PDGS of 2 compared to controls (29 and 30 μM). In the SLE patient examined at the time of flare (T1) and after symptom resolution (T2), Fall Time AUC decreased in 4 of 6 fingers (Fig 3C), suggesting improvement.

Conclusion: These data support the use of FDOI and GLOIS to reliably detect MSK US-confirmed arthritis in SLE joints and to monitor disease activity. Optical imaging shows promise as a non-invasive, objective tool for lupus arthritis assessment in clinical care and trials. Further development is warranted and ongoing.

Supporting image 1Figure 1. Glove-like optical imaging system (GLOIS) in the Evaluation of Lupus Arthritis

The top part of the figure exhibits the glove-like optical imaging system (GLOIS), which comprises a control module, four optical imaging patches, a flexible printed circuit (FPC) connecting band, and an adjustable flexible fixation band. The optical imaging patches deliver light into the affected joint and measure the resulting reflected and transmitted light. Each patch comprises two source-detector modules spaced 10 mm apart, each with three light-emitting diodes (LEDs) (wavelength λ = 880 nm, 660 nm, and 530 nm) and a photodiode. The patches are connected to each other and the control module via the flexible connecting band at 15 mm spacings, allowing the patches to be wrapped around the proximal inter-phalangeal (PIP) joint. The band and patches are fixed to the finger using a 3D-printed flexible fixation band.

The bottom part of the figure shows a typical signal trace measured by GLOIS for one source detector, showing significant events, including the baseline measurement (A), the sphygmomanometer cuff inflation (B) to the subject’s diastolic blood pressure causing a complete venous occlusion and partial arterial occlusion , and the release of pressure (C) accompanied by 60 more seconds of measurement.

Supporting image 2Figure 2. Evaluation of lupus arthritis by frequency domain optical imaging (FDOI) in comparison to musculoskeletal ultrasound (MSK US)

ROC curve (A) and discriminant linear analyses (B) of frequency domain optical imaging (FDOI) in comparison to musculoskeletal ultrasound (MSK US) evaluation of lupus arthritis. The three parameters of choice for the discriminant analysis include the mean of the scattering coefficient, variation of the absorption coefficient, and percentage of total finger volume interested.

Joints with no/minimal arthritis (PDGS 0 or 1) and moderate/severe arthritis (PDGS 2 or 3) show significantly different mean and standard error of scattering (C) and absorption (D) in reconstructed optical data.

Supporting image 3Fig 3. Glove-like optical imaging system (GLOIS) evaluation of joints in patients with lupus and healthy controls

3D Reconstructions of the total hemoglobin (HbT) concentrations in a healthy subject and control subjects at the time of pressure release (A) and 30 seconds after pressure release (B). AUC of Fall Time decreases for 4 of the 6 fingers (C) during and after a lupus arthritis flare.


Disclosures: W. Tang: None; G. Rosas Chavez: None; L. Khalili: None; A. Nordmann-Gomes: None; S. Suh: None; A. Marone: None; M. Bardien: None; S. Kim: None; L. Geraldino-Pardilla: Aurinia, 2, 6, Bristol-Myers Squibb(BMS), 1, 2, 6; A. Hielscher: None; A. Askanase: AbbVie, 2, Amgen, 2, 5, AstraZeneca, 2, 5, Aurinia, 2, 5, BMS, 2, 5, Eli Lilly, 5, Genentech, 2, 5, GSK, 2, 5, Idorsia, 2, 5, Janssen, 2, NKARTA, 5, Pfizer, 2, Sanofi, 5, UCB, 2, 5.

To cite this abstract in AMA style:

Tang W, Rosas Chavez G, Khalili L, Nordmann-Gomes A, Suh S, Marone A, Bardien M, Kim S, Geraldino-Pardilla L, Hielscher A, Askanase A. Comparison of Optical Imaging with Musculoskeletal Ultrasound in Assessment of PIP Joints of Systemic Lupus Erythematosus Patients [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/comparison-of-optical-imaging-with-musculoskeletal-ultrasound-in-assessment-of-pip-joints-of-systemic-lupus-erythematosus-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-optical-imaging-with-musculoskeletal-ultrasound-in-assessment-of-pip-joints-of-systemic-lupus-erythematosus-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology